FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

895431005: Azilsartan medoxomil potassium (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2021. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
4023387015 Azilsartan medoxomil potassium en Synonym Active Entire term case insensitive SNOMED CT core module
4023388013 Azilsartan medoxomil potassium (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Azilsartan medoxomil potassium Is a Heterocyclic compound true Inferred relationship Existential restriction modifier
Azilsartan medoxomil potassium Is a Substance with angiotensin II receptor antagonist mechanism of action true Inferred relationship Existential restriction modifier
Azilsartan medoxomil potassium Is modification of Azilsartan medoxomil true Inferred relationship Existential restriction modifier
Azilsartan medoxomil potassium Has disposition Angiotensin II receptor antagonist true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely azilsartan medoxomil (as azilsartan medoxomil potassium) 20 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Azilsartan medoxomil potassium Inferred relationship Existential restriction modifier 1
Azilsartan medoxomil 40mg tablets Has precise active ingredient True Azilsartan medoxomil potassium Inferred relationship Existential restriction modifier 1
Azilsartan medoxomil 80mg tablets Has precise active ingredient True Azilsartan medoxomil potassium Inferred relationship Existential restriction modifier 1
Azilsartan medoxomil 40mg tablets Has specific active ingredient True Azilsartan medoxomil potassium Inferred relationship Existential restriction modifier
Azilsartan medoxomil 80mg tablets Has specific active ingredient True Azilsartan medoxomil potassium Inferred relationship Existential restriction modifier
Azilsartan medoxomil 20mg tablets Has specific active ingredient True Azilsartan medoxomil potassium Inferred relationship Existential restriction modifier
Edarbi 40mg tablets (Takeda UK Ltd) Has specific active ingredient True Azilsartan medoxomil potassium Inferred relationship Existential restriction modifier
Azilsartan medoxomil 20mg tablets 28 tablet Has specific active ingredient True Azilsartan medoxomil potassium Inferred relationship Existential restriction modifier
Edarbi 80mg tablets (Takeda UK Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient True Azilsartan medoxomil potassium Inferred relationship Existential restriction modifier
Edarbi 40mg tablets (Takeda UK Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient True Azilsartan medoxomil potassium Inferred relationship Existential restriction modifier
Azilsartan medoxomil 40mg tablets 28 tablet Has specific active ingredient True Azilsartan medoxomil potassium Inferred relationship Existential restriction modifier
Edarbi 80mg tablets (Takeda UK Ltd) Has specific active ingredient True Azilsartan medoxomil potassium Inferred relationship Existential restriction modifier
Edarbi 20mg tablets (Takeda UK Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient True Azilsartan medoxomil potassium Inferred relationship Existential restriction modifier
Azilsartan medoxomil 80mg tablets 28 tablet Has specific active ingredient True Azilsartan medoxomil potassium Inferred relationship Existential restriction modifier
Edarbi 20mg tablets (Takeda UK Ltd) Has specific active ingredient True Azilsartan medoxomil potassium Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start